ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 114 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,542 | -95.8% | 15,944 | -85.9% | 0.01% | -96.7% |
| Q3 2022 | $1,217,000 | -46.0% | 112,701 | -43.0% | 0.18% | -7.5% |
| Q2 2022 | $2,254,000 | +2.4% | 197,719 | -18.2% | 0.20% | +5.3% |
| Q1 2022 | $2,201,000 | -20.7% | 241,592 | +29.8% | 0.19% | -10.4% |
| Q4 2021 | $2,776,000 | +84.0% | 186,082 | +216.9% | 0.21% | +95.4% |
| Q3 2021 | $1,509,000 | -64.7% | 58,727 | -64.2% | 0.11% | -61.7% |
| Q2 2021 | $4,273,000 | +48.9% | 163,828 | +101.6% | 0.28% | +36.9% |
| Q1 2021 | $2,869,000 | -15.0% | 81,265 | -39.2% | 0.21% | -9.6% |
| Q4 2020 | $3,376,000 | -7.7% | 133,741 | +38.0% | 0.23% | -5.4% |
| Q3 2020 | $3,656,000 | +800.5% | 96,943 | +519.8% | 0.24% | +864.0% |
| Q4 2019 | $406,000 | – | 15,640 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |